1.Incidentally found cystic lymphangioma of the adrenal gland in an elderly male cadaver
Hee Cheol KIM ; Yunji KANG ; Young Hee MAENG ; Jinu KIM ; Sang Pil YOON
Yeungnam University Journal of Medicine 2019;36(3):265-268
Adrenal cystic lymphangiomas are extremely rare entities that are often identified incidentally, with less than 60 cases reported to date. We found a protruding ovoid mass consisting of a multiloculated cystic lesion within right adrenal gland in the cadaver of a 75-year-old Korean man. The epithelial cells lining the adrenal cyst were diffusely positive for cluster of differentiation 31 and podoplanin, and negative for pan-cytokeratin. The histopathological diagnosis confirmed a cystic lymphangioma arising from the adrenal gland. Post-mortem findings of the present case are discussed based on the clinicopathological features of adrenal cystic lymphangiomas.
Adrenal Glands
;
Aged
;
Cadaver
;
Diagnosis
;
Epithelial Cells
;
Humans
;
Lymphangioma
;
Lymphangioma, Cystic
;
Male
2.Incidentally found cystic lymphangioma of the adrenal gland in an elderly male cadaver
Hee Cheol KIM ; Yunji KANG ; Young Hee MAENG ; Jinu KIM ; Sang Pil YOON
Yeungnam University Journal of Medicine 2019;36(3):265-268
Adrenal cystic lymphangiomas are extremely rare entities that are often identified incidentally, with less than 60 cases reported to date. We found a protruding ovoid mass consisting of a multiloculated cystic lesion within right adrenal gland in the cadaver of a 75-year-old Korean man. The epithelial cells lining the adrenal cyst were diffusely positive for cluster of differentiation 31 and podoplanin, and negative for pan-cytokeratin. The histopathological diagnosis confirmed a cystic lymphangioma arising from the adrenal gland. Post-mortem findings of the present case are discussed based on the clinicopathological features of adrenal cystic lymphangiomas.
3.Erratum: Plasmacytoid Dendritic Cells Contribute to the Protective Immunity Induced by Intranasal Treatment with Fc-fused Interleukin-7 against Lethal Influenza Virus Infection.
Moon Cheol KANG ; Han Wook PARK ; Dong Hoon CHOI ; Young Woo CHOI ; Yunji PARK ; Young Chul SUNG ; Seung Woo LEE
Immune Network 2017;17(6):460-460
In the publication by Kang et al., typographical error has been detected in acknowledgements.
4.Plasmacytoid Dendritic Cells Contribute to the Protective Immunity Induced by Intranasal Treatment with Fc-fused Interleukin-7 against Lethal Influenza Virus Infection.
Moon Cheol KANG ; Han Wook PARK ; Dong Hoon CHOI ; Young Woo CHOI ; Yunji PARK ; Young Chul SUNG ; Seung Woo LEE
Immune Network 2017;17(5):343-351
Developing a novel vaccine that can be applied against multiple strains of influenza virus is of utmost importance to human health. Previously, we demonstrated that the intranasal introduction of Fc-fused IL-7 (IL-7-mFc), a long-acting cytokine fusion protein, confers long-lasting prophylaxis against multiple strains of influenza A virus (IAV) by inducing the development of lung-resident memory-like T cells, called T(RM)-like cells. Here, we further investigated the mechanisms of IL-7-mFc-mediated protective immunity to IAVs. First, we found that IL-7-mFc treatment augments the accumulation of pulmonary T cells in 2 ways: recruiting blood circulating T cells into the lung and expanding T cells at the lung parenchyma. Second, the blockade of T cell migration from the lymph nodes (LNs) with FTY720 treatment was not required for mounting the protective immunity to IAV with IL-7-mFc, suggesting a more important role of IL-7 in T cells in the lungs. Third, IL-7-mFc treatment also recruited various innate immune cells into the lungs. Among these cells, plasmacytoid dendritic cells (pDCs) play an important role in IL-7-mFc-mediated protective immunity through reducing the immunopathology and increasing IAV-specific cytotoxic T lymphocyte (CTL) responses. In summary, our results show that intranasal treatment with IL-7-mFc modulates pulmonary immune responses to IAV, affecting both innate and adaptive immune cells.
Cell Movement
;
Dendritic Cells*
;
Fingolimod Hydrochloride
;
Humans
;
Influenza A virus
;
Influenza, Human*
;
Interleukin-7*
;
Lung
;
Lymph Nodes
;
Lymphocytes
;
Orthomyxoviridae*
;
T-Lymphocytes
5.Active and Passive Smoking, BRAF(V600E) Mutation Status, and the Risk of Papillary Thyroid Cancer: A Large-Scale Case-Control and Case-Only Study
Kyoung Nam KIM ; Yunji HWANG ; Kyungsik KIM ; Kyu Eun LEE ; Young Joo PARK ; June Young CHOI ; Do Joon PARK ; BeLong CHO ; Daehee KANG ; Sue K PARK
Cancer Research and Treatment 2019;51(4):1392-1399
PURPOSE: The association between tobacco smoking and thyroid cancer remains uncertain. We evaluated the associations of active and passive smokingwith the risk of papillary thyroid cancer (PTC), the most common type of thyroid cancer, and with the BRAF(V600E) mutation, the most common oncogenic mutation in PTC related to poor prognosis. MATERIALS AND METHODS: We conducted this study with newly diagnosed PTC patients (n=2,142) and community controls (n=21,420) individually matched to cases for age and sex. Information on active and passive smoking and potential confounders were obtained from structured questionnaires, anthropometric measurements, and medical records. BRAF(V600E) mutation status was assessed in PTC patients. We evaluated the associations of active and passive smoking with PTC and BRAF(V600E) mutation risk using conditional and unconditional logistic regression models, respectively. RESULTS: We did not find associations between exposure indices of active and passive smoking and PTC risk in both men and women, except for the association between current smoking and lower PTC risk. Cumulative smoking ≥ 20 pack-years was associated with lower BRAF(V600E) mutation risk in male PTC patients (odds ratio [OR], 0.55; 95% confidence interval [CI], 0.30 to 1.00). The CI for the association was wider in female PTC patients (OR, 0.23; 95% CI, 0.02 to 2.62), possibly owing to a smaller sample size in this stratum. CONCLUSION: We did not find consistent associations between active and passive smoking and PTC risk. Cumulative smoking ≥ 20 pack-years was associated with lower BRAF(V600E) mutation risk in male PTC patients.
Case-Control Studies
;
Female
;
Humans
;
Logistic Models
;
Male
;
Medical Records
;
Prognosis
;
Sample Size
;
Smoke
;
Smoking
;
Thyroid Gland
;
Thyroid Neoplasms
;
Tobacco Smoke Pollution
6.The Effect of Breastfeeding Duration and Parity on the Risk of Epithelial Ovarian Cancer: A Systematic Review and Meta-analysis.
Ho Kyung SUNG ; Seung Hyun MA ; Ji Yeob CHOI ; Yunji HWANG ; Choonghyun AHN ; Byoung Gie KIM ; Yong Man KIM ; Jae Weon KIM ; Sokbom KANG ; Jaehoon KIM ; Tae Jin KIM ; Keun Young YOO ; Daehee KANG ; Suekyung PARK
Journal of Preventive Medicine and Public Health 2016;49(6):349-366
OBJECTIVES: We conducted a systematic review and meta-analysis to summarize current evidence regarding the association of parity and duration of breastfeeding with the risk of epithelial ovarian cancer (EOC). METHODS: A systematic search of relevant studies published by December 31, 2015 was performed in PubMed and EMBASE. A random-effect model was used to obtain the summary relative risks (RRs) and 95% confidence intervals (CIs). RESULTS: Thirty-two studies had parity categories of 1, 2, and ≥3. The summary RRs for EOC were 0.72 (95% CI, 0.65 to 0.79), 0.57 (95% CI, 0.49 to 0.65), and 0.46 (95% CI, 0.41 to 0.52), respectively. Small to moderate heterogeneity was observed for one birth (p<0.01; Q=59.46; I²=47.9%). Fifteen studies had breastfeeding categories of <6 months, 6-12 months, and >13 months. The summary RRs were 0.79 (95% CI, 0.72 to 0.87), 0.72 (95% CI, 0.64 to 0.81), and 0.67 (95% CI, 0.56 to 0.79), respectively. Only small heterogeneity was observed for <6 months of breastfeeding (p=0.17; Q=18.79, I²=25.5%). Compared to nulliparous women with no history of breastfeeding, the joint effects of two births and <6 months of breastfeeding resulted in a 0.5-fold reduced risk for EOC. CONCLUSIONS: The first birth and breastfeeding for <6 months were associated with significant reductions in EOC risk.
Birth Order
;
Breast Feeding*
;
Female
;
Humans
;
Joints
;
Ovarian Neoplasms*
;
Parity*
;
Parturition
;
Population Characteristics
;
Reproduction
;
Risk Factors